DiogenX logo

DiogenX jobs and careers

Marseille, France

About DiogenX

DiogenX is a preclinical stage biotech company, specializing in the development of pancreatic beta-cell modulators for the treatment of Type 1 (T1D) and Type 2 Diabetes (T2D). The company, which also has research labs in Nice, France, aims to discover and develop a candidate molecule that regenerates pancreatic insulin-producing cells in patientswith diabetes, offering benefits in terms of quality of life and survival. It was discovered in the laboratory of Dr. Patrick Collombat (Inserm, CNRS, Nice University) in France, DiogenX is developing an innovative therapy with the potential to be the first beta-cell regeneration drug for diabetes.

Founded in 2019 by Benjamin Charles, Jean-Pascal Tranié and Patrick Collombat.

Founded
2019
Employees
1 to 10
Total funding
$38M
Headquarters
Marseille

Leadership

The top of DiogenX's org chart, with how many people report into each leader.

BC

Benjamin CHARLES

Chief Executive Officer - Co-founder

4 reports

HSPhoto of Helene Sicard

Helene Sicard

Chief Development Officer

1 report

KOPhoto of Klara Owen

Klara Owen

Chief Medical Officer

RPPhoto of Renaud Perret

Renaud Perret

Director Of Finance & Administration